Free Trial
→ The Trump Dump is starting; Get out of stocks now? (From Paradigm Press) (Ad) Free ELVN Stock Alerts

Enliven Therapeutics (ELVN) SEC Filings & 10K Form

Enliven Therapeutics logo
$20.68 +0.04 (+0.17%)
Closing price 01:04 PM Eastern
Extended Trading
$20.68 0.00 (0.00%)
As of 04:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Enliven Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
07/01/2025
3:42 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/25/2025
3:05 PM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/24/2025
4:36 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/18/2025
5:22 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2025
4:30 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
Form SCHEDULE 13D/A
06/17/2025
3:24 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/16/2025
5:44 AM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/13/2025
8:39 PM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form 424B5
06/13/2025
5:17 AM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form 424B5
06/13/2025
5:26 AM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form S-3MEF
06/13/2025
5:05 AM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2025
5:25 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
3:21 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/05/2025
3:53 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2025
3:55 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2025
4:34 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/03/2025
4:14 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Lyssikatos Joseph P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/29/2025
4:38 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025
5:29 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/21/2025
5:31 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/19/2025
3:21 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Lyssikatos Joseph P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/19/2025
3:22 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2025
5:48 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
5:42 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
5:43 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2025
5:59 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/28/2025
3:08 PM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form DEFA14A
04/28/2025
3:12 PM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form ARS
04/21/2025
4:55 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/09/2025
3:25 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/07/2025
3:09 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2025
6:37 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/27/2025
3:01 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Hohl Benjamin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2025
6:37 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2025
4:49 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
4:42 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2025
3:18 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Lyssikatos Joseph P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/18/2025
4:33 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
Form 144/A
03/18/2025
4:22 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
Form 144/A
03/18/2025
3:06 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/17/2025
3:14 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Elon’s BIGGEST warning yet? (Ad)

Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.

Click here to see why Tesla's about to prove everyone wrong... again.
03/13/2025
4:05 PM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
03/07/2025
3:18 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
5:02 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
7:07 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
3:10 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Hohl Benjamin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
4:02 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
2:45 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
8:17 AM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
Form SCHEDULE 13G/A
02/10/2025
4:36 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Gupta Rishi (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:38 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Heyman Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:39 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kunkel Lori Anne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:40 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Phillips Andrew John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:25 PM		Collins Helen Louise (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:27 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:28 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:29 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:32 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:33 PM		Ballal Rahul D. (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:34 PM		Bauer Jake (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
4:35 PM		Derynck Mika K (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
6:06 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/29/2025
6:21 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:37 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Hohl Benjamin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2025
3:06 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/14/2025
3:01 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/10/2025
4:31 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:43 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/07/2025
3:21 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/31/2024
4:18 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
3:33 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Hohl Benjamin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/16/2024
3:15 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/02/2024
4:18 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/15/2024
3:28 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
4:46 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
RA CAPITAL MANAGEMENT, L.P. (Filed by)
Form SC 13G/A
11/14/2024
4:48 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G/A
11/14/2024
3:24 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Form SC 13G/A
11/13/2024
4:55 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Polar Capital Holdings Plc (Filed by)
Form SC 13G
11/13/2024
3:15 PM		Enliven Therapeutics, Inc. (Filer)
Enliven Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
1:17 PM		BlackRock, Inc. (Filed by)
Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Form SC 13G
10/30/2024
5:04 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/24/2024
1:02 PM		BlackRock, Inc. (Filed by)
Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Form SC 13G
10/22/2024
3:18 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Heyman Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
3:19 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Hohl Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
3:21 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
3:22 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
3:23 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Patel Anish (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/22/2024
3:17 PM		Collins Helen Louise (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/18/2024
5:42 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Patel Anish (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
4:27 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Heyman Richard A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
4:42 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Lyssikatos Joseph P (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Trump Makes Major Crypto Announcement (Ad)

Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design.

Click Here to Discover our #1 crypto for the Trump Presidency Bull Run now!
10/18/2024
4:10 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Heyman Richard A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
4:17 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Kintz Samuel (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
3:57 PM		Collins Helen Louise (Reporting)
Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/18/2024
4:00 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Hohl Benjamin (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/17/2024
4:06 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Heyman Richard A. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/15/2024
3:38 PM		Enliven Therapeutics, Inc. (Subject)
Enliven Therapeutics (Subject)
Heyman Richard A. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/10/2024
7:36 PM		Ballal Rahul D. (Reporting)
Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
7:38 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Kintz Samuel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/10/2024
7:39 PM		Enliven Therapeutics, Inc. (Issuer)
Enliven Therapeutics (Issuer)
Lyssikatos Joseph P (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:ELVN) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners
Here's the last trade you should make before heading out for the weekend tomorrow.
Make this one trade at 2:59 PM on Friday afternoon, and you'll thank me on Monday morning.
Timothy Sykes | Sponsored
This Signal Only Flashes Once Every 4 Years – And It Just Triggered
This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...
Crypto Swap Profits | Sponsored
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...
American Alternative | Sponsored
Trump’s New Order Could Boost Social Security Benefits by 400%
If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...
InvestorPlace | Sponsored
A grave, grave error.
Famed financial analyst, Porter Stansberry, calls this technology “The Final Frontier” because it holds the ke...
Porter & Company | Sponsored
This Crypto Is Set to Explode in January
Free summit: How to profit from the Coinbase-Deribit deal Our hedge fund experts know exactly what this mea...
Crypto 101 Media | Sponsored
The $15 Gold Fund That Pays Up to $1,152/Month
Gold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...
Investors Alley | Sponsored
Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...
Brownstone Research | Sponsored